This conference strives to improve basic cardiovascular regulation through new therapies and insights in cardiovascular disease, as well as research in fields like microRNAs, cardiac gene and cell therapy, cardiac development, as well as tissue engineering and iPS cells.
BCVS convenes basic and translational cardiovascular scientists from around the world with the common goal to discover pathways to cardiovascular therapeutics and promoting cardiovascular health. This meeting has become the “go to” meeting for intra- and interdisciplinary cross-fertilization of ideas and incorporation of new approaches from the general scientific community and plays a pivotal role in the training of junior scientists and trainees.
The program will be of special interest to basic cardiovascular scientists, molecular/ cellular biologists, physiologists, translational investigators, clinical trialists, practicing cardiologists, cardiovascular nurses and pharmacists. In addition, the symposium will be of great value to scientists and executives of pharmaceutical companies and biotechnology firms who are in the cardiovascular space.
The program will be of special interest to basic cardiovascular scientists, molecular/cellular biologists, physiologists, translational investigators, clinical trialists, practicing cardiologists, cardiovascular nurses and pharmacists. In addition, the conference will be of great value to scientists and executives of pharmaceutical companies and biotechnology firms who are in the cardiovascular space.
It is our pleasure to invite you to the Basic Cardiovascular Sciences 2017 Scientific Sessions! The American Heart Association’s annual meeting offers a unique opportunity to showcase your company to your customers and prospects.
With an anticipated professional attendance of more than 600 you, as an exhibitor, have the opportunity to interact with colleagues from many disciplines including:
The American Heart Association is the nation’s oldest and largest voluntary organization dedicated to fighting heart disease and stroke. Founded by six cardiologists in 1924, our organization now includes more than 22.5 million volunteers and supporters. We fund innovative research, fight for stronger public health policies, and provide critical tools and information to save and improve lives. Our nationwide organization includes 156 local offices and more than 3,000 employees. We moved our national headquarters from New York to Dallas in 1975 to be more centrally located. The American Stroke Association was created as a division in 1997 to bring together the organization’s stroke-related activities.
|BCVS Scientific Sessions 2020 - Basic Cardiovascular Sciences||Chicago||Illinois||532 e||12||Jul 27, 2020|
|BCVS Scientific Sessions 2019 - Basic Cardiovascular Sciences||Boston||Massachusetts||532||12||Jul 29, 2019|
|BCVS Scientific Sessions 2018 - Basic Cardiovascular Sciences||San Antonio||Texas||570||3||Jul 30, 2018|
|International Stroke Conference 2014||San Diego||California||-||-||Feb 12, 2014|
|International Stroke Conference 2015||Nashville||Tennessee||-||-||Feb 11, 2015|
|American Society of Extra-corporeal Technology 2015 Conference||Tampa||Florida||-||-||Apr 14, 2015|
|International Stroke Conference 2016 (ISC)||Los Angeles||California||-||-||Feb 17, 2016|
|American Society of Extra-corporeal Technology 2016 Conference||Colorado Springs||Colorado||-||-||Mar 15, 2016|